Purchase Order 75N92E24P00254
Award Date
9/1/24
Potential Completion Date
3/31/25
Potential Value
$12K
Federal Agency
National Human Genome Research Institute
Awardee
UK Biobank LIMITED
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order contract, valued at $12,369.70, was awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The contract provides Tier 3 access to UK Biobank's large-scale, de-identified biomedical database containing genetic, lifestyle, and health information from over 500,000 participants in the United Kingdom. This data access supports biomedical research projects across...
This is a $12,120 firm fixed-price purchase order awarded by the National Cancer Institute, part of the National Institutes of Health, to UK Biobank Limited, a non-profit organization. The contract provides UK Biobank Limited's large-scale biomedical database containing de-identified genetic, lifestyle, and health information from over 500,000 UK participants as a research resource for approved scientific researchers to analyze. The award, with a completion date of February 6, 2026,...
This firm fixed-price purchase order contract was awarded by the National Eye Institute (NEI), a component of the National Institutes of Health (NIH), to UK Biobank Limited, a non-profit organization. The $11,630.34 contract provides access to UK Biobank's large-scale biomedical database containing genetic, lifestyle, and health information from over 500,000 UK participants. This biobank serves as a research resource for approved scientific studies, and the contract facilitates projects...
This purchase order awards UK Biobank Limited $12,934.99 to provide Tier 3 access fees under a potential value of the same amount. As a non-profit organization, the contractor will deliver its standard biobank datasets and related laboratory and testing services to the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute in Bethesda, Maryland by November 14, 2024. The firm fixed price contract vehicle was awarded on November 15, 2023...
UK Biobank Limited has been awarded a $13,500 purchase order by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to provide laboratory and testing services. The firm fixed price contract runs from December 2023 through March 2026 and will be performed by UK Biobank in Great Britain. No additional details were provided on the original solicitation or work scope. The award does not appear to be associated with a...
The National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism awarded UK Biobank Limited a three-year, firm fixed price purchase order valued at approximately thirteen thousand three hundred eighty-eight U.S. dollars to provide access to the United Kingdom Biobank dataset. As the prime contractor, UK Biobank Limited will deliver its biomedical database of genetic and health information to support research efforts of the National Institute on Alcohol Abuse and Alcoholism....
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $22,136.63 firm fixed price purchase order to the University of Oxford for biological material with DNA isolation. The contract has no set-aside designation and calls for the delivery of products and/or services related to biological samples containing DNA to be provided by the prime contractor, the University of Oxford. Performance will occur in Bethesda, Maryland at the...
This is a federal contract awarded by the Centers for Disease Control and Prevention (CDC) to Genome Research LIMITED, doing business as the Wellcome Sanger Institute, a non-profit genomics research organization based in the United Kingdom. The contract, valued at $216,075.00, is for DATAFLO.IO services. It is a definitive, firm fixed-price contract with a completion date of September 29, 2018. The contract does not have a set-aside designation. Genome Research LIMITED has previously received...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $23,866.80 firm fixed price purchase order to the University of Oxford for DNA isolation, bespoke and concentration services. The contract has no set-aside designation and requires completion by August 26, 2020. As the lead federal agency for genomic research, the award supports the National Institutes of Health's mission to analyze and understand the building blocks of...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm-fixed-price purchase order contract to Dnanexus, Inc. for a "Biobank Research Analysis Platform." The $12,569.50 contract does not have a set-aside designation and is for the delivery of cloud-based genomics data management and analysis services from Dnanexus, a for-profit organization. Through this award, Dnanexus will provide bioinformatics software,...